Stockreport

Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain [Seeking Alpha]

Elevance Health, Inc.  (ELV) 
PDF ELV's benefit expense ratio remains elevated at 90%, with medical inflation and higher utilization driving cost pressures and reduced profitability. Guidance for 2026 [Read more]